|
A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH). Clinical Trials Resources presented on Clinical Trials Search is not meant to be a substitute for proven health advice, calls or treatment with a real medical. We aren't mDs. Always consult your doctor on A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH). conditions. Clinical Trials Search.org is a website dedicated to listing clinical research studies in human subjects. A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH). Clinical research trials and A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH). healthcare trials take place in a lot of of localities throughout the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials typically assess the effectiveness of new does drugs. The function of the studies / projects is to figure out specific human medical questions. Clinical trials are a popular means for doctors, government agencies, and private sector corporations to find cures for all varieties of conditions, like A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH).. A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH). Clinical Trials and other clinical trials allow volunteers to access health treatment options before they are available to the masses. Many times the subjects receive professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH). clinical trial. Human subjects often obtain the finest healthcare possible for their A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH). condition. Hazards are a reality, nevertheless, and might include additional or frequent dr. calls, health hazards (potentially life-jeopardizing), and/or the treatment being uneffective. Trials are federally regulated with stern guidelines to protect clinical trials patients.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH).  A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH).
A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH).
For Condition: Prostatic Hyperplasia
Status: Recruiting
Sponsor(s): Milkhaus Laboratory ,
Synopsis: Patients who are currently symptomatic and have been diagnosed with BPH by a physician may qualify for this 20-week study. Patients must not be diabetic, must not have prostate cancer and must not have had any surgery to repair your prostate or treat your BPH. Patients will first undergo a phone screening to confirm their eligibility and interest and to rule out any exclusionary history or medications. Eligible patients will be scheduled to come in to the clinic to sign an Informed Consent Form. Patients will then undergo blood and urine tests, a complete physical examination and history and answer several questionnaires to determine their eligibility. Patients will have a total of at least 7-8 visits over 20 weeks to the clinic during this study.Qualified patients receive free study medication, free medical care (physical examinations, EKG, laboratory tests) for the duration of the study.
Details: Patients must be willing to discontinue their current medications being taken for BPH for specified time periods before they become eligible. These include: Proscar, Saw Palmetto, and any "alpha-blocker" drugs. Patients with high blood pressure must be on an acceptable medication that controls this condition. Medications for other conditions may disqualify a patient from eligibility.Patients who are diabetic are not eligible for this study. All patients will, at some time during the study, receive placebo (inactive substance). The study medication is given twice a day in liquid form under the tongue. There is a 33% chance that you would receive placebo for the duration of the study. Neither you nor your doctor will know which treatment you are receiving.
Eligibility:
Study Type: Interventional, Treatment, Randomized, Double-Blind, Placebo Control, Single Group Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 45 Years/80 Years
Genders: Male
Protocol Entry Criteria: - Have an enlarged prostate by DRE (digital rectal examination); - Have a diagnosis of BPH; - Have documented symptoms (frequency; urgency; nighttime urination; reduced flow); - Have a documented urinary flow rate as required
Total Enrollment: 350
Location and Contact Information:
Michael Godschalk, MD *Recruiting*
Richmond, Virginia, 23249
United States
Recruiting Tammy Creasy 804-675-5705
Joel Kaufman, MD *Recruiting*
Aurora, Colorado, 80012
United States
Recruiting Jamie Yingst 303-755-1625
Roger Fincher, MD *Recruiting*
Spokane, Washington, 99202
United States
Recruiting Sarah Collins 509-747-7900
Gary Friedlander, MD *Recruiting*
Rockville, Maryland, 20850
United States
Recruiting Wendy Clover 301-315-6081
Donald Bergner, MD *Recruiting*
Clearwater, Florida, 33761
United States
Recruiting Shirley Spiot 727-724-3316
H. Pat Hezmall, MD *Recruiting*
Ft. Worth, Texas, 73104
United States
Recruiting Kathy Marshall 817-332-8595
Douglas Young, MD *Recruiting*
Fair Oaks, California, 95628
United States
Recruiting Stephanie Lanam 916-961-7593
Rodney Anderson, MD *Recruiting*
Stanford, California, 94305
United States
Recruiting Nushin Namazi 650-724-0084
Sheldon Freedman, MD *Recruiting*
Las Vegas, Nevada, 89109
United States
Recruiting Lisa Boyak 702-732-0282
Ira Klimberg, MD *Recruiting*
Ocala, Florida, 34474
United States
Recruiting Rustina Jones 352-237-3949
Richard Landau, MD *Recruiting*
Sellersville, Pennsylvania, 18960
United States
Recruiting LouAnn Crist 215-257-3066
Eugene Dula, MD *Recruiting*
Van Nuys, California, 91405
United States
Recruiting Sandro Gomez 818-901-8541
Edward Loizides, MD *Recruiting*
Bay Shore, New York, 11706
United States
Recruiting Diana Mauceri 631-665-3737
Charles White, MD *Recruiting*
Mobile, Alabama, 36608
United States
Recruiting Julie Clark 251-639-1661
Additional Information:
Study ID Numbers: ML-BPH-01;
Study Start Date: April 2002
Record last reviewed: August 2002
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00044226
Other Prostatic Hyperplasia Studies:
1. Clinical Trial in Males with BPH (Enlarged Prostate)
2. A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH).
3. Medical Therapy of Prostatic Symptoms (MTOPS)
Related Studies:
Other Prostatic Hyperplasia Clinical Trials
Other California Clinical Trials
Other Fair Oaks Clinical Trials
A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH).
|
|
|
|
|
|
|
|
